Tucatinib
Brand name: Tukysa
Tucatinib comes in 4 pill versions in our database, in 2 strengths, from 2 manufacturers. Check the imprint to tell them apart.
Tucatinib pill images
50 mg 2 pills
- TUC 50 Tucatinib 50 mg Yellow, round, 8 mm Used for breast cancer
- TUC 50 Tucatinib 50 mg Yellow, round Used for breast cancer
150 mg 2 pills
What is Tucatinib used for?
Tucatinib is used for breast cancer.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Metastatic Breast Cancer
TUKYSA is indicated in combination with trastuzumab and capecitabine for treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases, who have received one or more prior anti-HER2-based regimens in the metastatic setting.
Unresectable or Metastatic Colorectal Cancer
TUKYSA is indicated in combination with trastuzumab for the treatment of adult patients with RAS wild-type, HER2-positive unresectable or metastatic colorectal cancer that has progressed following treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.
This indication is approved under accelerated approval based on tumor response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
From the FDA-approved label on DailyMed (published Nov 05, 2024).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.